Back to
UBS Group AG
AUTLShowing 8 of 29 quarters
Position history for
UBS Group AG's holdings in AUTOLUS THERAPEUTICS LTD
Yes. Ubs holds 1,516,991 shares of AUTL (Autolus Therapeutics), worth $2.4M, as of its Q2 2026 13F filing. It increased the position by 211,212 shares (+16.2%) from Q1 2026. Ubs has held AUTL since Q2 2019, across 29 quarterly 13F filings.
Current Value
$2.4M
Current Shares
1.5M
Total Value Change
+$1.9M
Total Shares Change
+1.4M
Quarter-by-Quarter History
Other major holders of AUTL: Blackstone Inc., WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC